Why Bother? Lab Monitoring in Beta-Lactam Outpatient Parenteral Antimicrobial Therapy
- 21 June 2022
- journal article
- letter
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 66 (6), e0057922
- https://doi.org/10.1128/aac.00579-22
Abstract
No abstract availableThis publication has 11 references indexed in Scilit:
- 2018 Infectious Diseases Society of America Clinical Practice Guideline for the Management of Outpatient Parenteral Antimicrobial TherapyaClinical Infectious Diseases, 2018
- Rates of and Risk Factors for Adverse Drug Events in Outpatient Parenteral Antimicrobial TherapyClinical Infectious Diseases, 2017
- Peripheral blood eosinophilia and hypersensitivity reactions among patients receiving outpatient parenteral antibioticsJournal of Allergy and Clinical Immunology, 2015
- A national survey of infectious disease practitioners on their use of outpatient parenteral antimicrobial therapy (OPAT)Infectious Diseases, 2014
- Monitoring of Outpatient Parenteral Antimicrobial Therapy and Implementation of Clinical Pharmacy Services at a Community Hospital Infusion UnitJournal of Pharmacy Practice, 2014
- The Impact of an Infectious Diseases Transition Service on the Care of Outpatients on Parenteral Antimicrobial TherapyJournal of Pharmacy Technology, 2013
- Association of laboratory test result availability and rehospitalizations in an outpatient parenteral antimicrobial therapy programmeJournal of Antimicrobial Chemotherapy, 2013
- Acute Kidney Injury Network: report of an initiative to improve outcomes in acute kidney injuryCritical Care, 2007
- Acute renal failure – definition, outcome measures, animal models, fluid therapy and information technology needs: the Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) GroupCritical Care, 2004
- Definitions for Sepsis and Organ Failure and Guidelines for the Use of Innovative Therapies in SepsisSocial psychiatry. Sozialpsychiatrie. Psychiatrie sociale, 1992